Vasculogenic Erectile Dysfunction: The Impact of Diet and Lifestyle - 23/02/21
Abstract |
Vasculogenic erectile dysfunction has been aptly called the “canary in the coal mine” for cardiovascular disease because it almost always precedes other manifestations of atherosclerotic cardiovascular disease, including myocardial infarction and stroke. It is common, associated with the presence of modifiable cardiovascular risk factors, and impacted by diet and lifestyle choices. This concise review provides an update on the use of dietary and other lifestyle interventions to improve vasculogenic erectile dysfunction and atherosclerotic cardiovascular disease.
Le texte complet de cet article est disponible en PDF.Keywords : Cardiovascular disease, Diet, Erectile dysfunction, Lifestyle
Plan
Funding: This publication was made possible, in part, by CTSA Grant Number TL1 TR001864 from the National Center for Advancing Translational Science (NCATS), a component of the National Institutes of Health (NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NIH. |
|
Conflicts of Interest: RJO reports research grants from the Purjes and Greenbaum Foundations, serving as consultant to Better Therapeutics, 2018; a speaker, Main Street Vegan Academy and International Plant-Based Nutrition Healthcare Conference; serving on the board of directors (uncompensated) for the T. Colin Campbell Center for Nutrition Studies; serving on the scientific advisory board (uncompensated) for the Physician Committee for Responsible Medicine; and serving as director, Cardiac Wellness Program, Montefiore Health System. AS reports being the author of the Penis Book and serving on the speakers bureaus of AbbVie pharmaceuticals and Metuchen Pharmaceuticals. JO'K reports major ownership interest in CardioTabs. MA reports receiving honoraria for speaking on nutrition, prevention, and cardiovascular disease; receiving royalties from the book, Body on Fire; and her position is partially funded by the Gatorade Foundation. SK reports serving as a consultant for Prime Therapeutics and Amgen; receiving research support for True Health, DSMB Member at Applied Clinical Intelligence; and serving as chair of board of directors at Mayo Clinic Support Services, Texas. DO reports receiving book royalties, lecture honoraria, and licensing fees from Sharecare. AMF reports serving as a consultant for Boehringer-Ingelheim and Actelion; nonpromotional speaking for Boehringer-Ingelheim; serving on advisory boards for Regeneron and The Medicines Company. KEA, KA, EJB, JL, DB, MM, CB, BW, NS, HH, TB, RB, and KR report none |
|
Authorship: All authors had access to the data and a role in writing this manuscript. |
Vol 134 - N° 3
P. 310-316 - mars 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?